1Pickup JC,Mattock MB,Chusney GD,et al .NIDDM as a disease of the innate immune system:Association of acute phase reactants and interleukin-6 with metabolic syndrome X [J].Diabeto-logia,1997;40:1286-1292.
2John A,Colwell MD.Inflammation and diabetic vascular complicat-ions[J].Diabetes Care,1999;22:1927-1928.
1Pandolfi A, Gisccari A. Acute hyperglycemia and acute hyperinsulinemia decrease plasm flbrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat [ J ] .Acta Diabetol,2001,38:71-76.
2Yamagishi S, Edelstein D, Du X. et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase [ J ]. J Biol Chem,2001,276:25096-25100.
3Unger R H, Zhou Y T. Lipotoxicity of β-cell in obesity and in other causes of fatty acid spillover [ J]. Diabetes, 2001,50(Suppl 1) :S118-S121.
4Barbora V, Christian W, Robert S, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J] . Diabetes, 2002,51 : 455-461.
5Robort S, Lindsay J K, Robext L H, et al. Gamma globulin level predict type 2 diabetes in the Pima Indian population[ J] Diabetes, 2001,50 : 1598-1603.
6Walder K,Lakshmi K,Janine S,et al.Tanis: a link between type 2 diabetes and inflammation? [J]. Diabetes,2002,51:1859-1866.
7Pradhan A D, Manson J E, Nader R, et al. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus[ J] .JAMA ,2001,286:327-334.
8Hrnciar J,Garbor D, Hrnciarova M, et al. Relation between cytokine (TNF-alpha, IL-6 and 1) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[ J]. Vnilr Lek, 1999,45 : 11-16.
9Esposito K, Nappo F, Marfella R, et al. Inflammation cytokine concentrations are acutely increased by hyperglycemia in human : role of oxidative stress[J ] . Circulation, 2002,106 : 2067-2072.
10Philip A, Subramanian R, Chunling L, et al. Adipose tissue tumor necrosis factor and interleukin-6, expression in obesity and insulin resistance [ J ]. Am J Physiol Endocrinol Metab,2001,280.E745-E751.
